On May 9, 2013, The U.S. Senate Committee on Health, Education, Labor and Pensions held a hearing, entitled "Pharmaceutical Compounding: Proposed Legislative Solution." Allan Coukell, a pharmacist and drug safety expert, testified on the need to strengthen oversight of the compounding industry.
In February, Pew, ASHP and AHA convened organizations representing pharmacists, doctors, hospitals and health care systems, the U.S. Centers for Disease Control, State boards of pharmacy and FDA. Based on stakeholder discussions, Pew, ASHP and AHA make a number of recommendations to improve oversight of pharmacy compounding at the federal and state levels.
This guidance comes after a series of compounding errors that have been associated with 1,022 adverse events, including 75 deaths, since 2001. Since May 2012, 53 people have died and over 700 have become ill after being injected with a contaminated medication made by a New England compounding pharmacy.
Read Allan Coukell's full testimony at Pew's health initiatives website.